ed continuous glucose monitors dexcom g4 dexcom g5 dexcom g6 enlite eversence freestyle libre freestyle libre 2 guardian sensor 3 guardian sensor 4  (Dexcom Inc)

Journal: Journal of Diabetes Science and Technology

Article Title: Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study

doi: 10.1177/19322968221113865

Figure Lengend Snippet: (a) CGM and POC glucose values plotted by time for a representative patient. Insulin infusion times are highlighted. (b) Density plot of POC blood glucose values during insulin infusion over all patients. The POC values are stratified by concurrent CGM use ( n = 2101) or no CGM use ( n = 1739). (c) Boxplot of average POC values for each patient ( n = 23) during insulin infusion when on CGM compared with off CGM. Lines connect the means of individual patients. Blue lines indicate an increase in average blood glucose when off CGM. Orange lines denote a decrease in average blood glucose when off CGM. Abbreviations: CGM, continuous glucose monitoring; POC, point-of-care.

Article Snippet: Continuous glucose monitoring sensors (Dexcom G6, Dexcom, San Diego, CA) were placed on hospitalized patients under an Emergency Operational Need Protocol approved by UC San Diego Health in 2020 allowing use in critically ill patients with COVID-19 requiring continuous IV insulin infusion for glycemic control.

Techniques:

Journal: Journal of Diabetes Science and Technology

Article Title: Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study

doi: 10.1177/19322968221113865

Figure Lengend Snippet: Clarke Error Grid of CGM versus POC blood glucose values in patients with COVID-19 ( n = 24). Dashed line indicates the 45° line. Data are rounded and may not add up to 100%. Two data points fell outside the range of this graph (POC glucose above 400 mg/dL) but would have fallen in the A or B zones. Abbreviations: CGM, continuous glucose monitoring; POC, point-of-care.

Article Snippet: Continuous glucose monitoring sensors (Dexcom G6, Dexcom, San Diego, CA) were placed on hospitalized patients under an Emergency Operational Need Protocol approved by UC San Diego Health in 2020 allowing use in critically ill patients with COVID-19 requiring continuous IV insulin infusion for glycemic control.

Techniques: